Zdrowie i gospodarka · 27/01/2003
FDA Clears Chymopapain 10,000 Units/Vial Injection for Approval
The FDA has determined that chymopapain 10,000 units/vial injection was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications for this medication.